 | |
| Discipline | Pharmacogenomics |
|---|---|
| Language | English |
| Edited by | David Gurwitz, Howard McLeod, Munir Pirmohamed |
| Publication details | |
| History | 2000–present |
| Publisher | |
| Frequency | 18/year |
| 2.350 (2016) | |
| Standard abbreviations | |
| ISO 4 | Pharmacogenomics |
| Indexing | |
| CODEN | PARMFL |
| ISSN | 1462-2416 (print) 1744-8042 (web) |
| OCLC no. | 55059877 |
| Links | |
Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.
Abstracting and indexing[edit]
The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]
References[edit]
- ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.